INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 136 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.94 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $86,000 | -18.9% | 3,711 | -13.8% | 0.00% | -50.0% |
| Q4 2020 | $106,000 | +82.8% | 4,303 | +208.0% | 0.00% | +100.0% |
| Q3 2020 | $58,000 | -86.1% | 1,397 | -57.7% | 0.00% | -93.8% |
| Q3 2018 | $417,000 | +658.2% | 3,301 | +247.5% | 0.02% | +300.0% |
| Q4 2017 | $55,000 | -54.5% | 950 | -54.5% | 0.00% | -63.6% |
| Q3 2017 | $121,000 | -46.2% | 2,086 | +12.1% | 0.01% | -50.0% |
| Q2 2017 | $225,000 | +7.1% | 1,861 | 0.0% | 0.02% | -15.4% |
| Q1 2017 | $210,000 | +26.5% | 1,861 | +21.6% | 0.03% | +8.3% |
| Q4 2016 | $166,000 | -27.2% | 1,531 | +10.6% | 0.02% | -31.4% |
| Q3 2016 | $228,000 | +26.7% | 1,384 | +9.5% | 0.04% | +25.0% |
| Q2 2016 | $180,000 | +350.0% | 1,264 | +375.2% | 0.03% | +211.1% |
| Q4 2015 | $40,000 | – | 266 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chicago Capital Management, LLC | 185,781 | $4,611,565 | 12.16% |
| Samsara BioCapital, LLC | 640,688 | $11,878,356 | 3.64% |
| ALPINE ASSOCIATES MANAGEMENT INC. | 2,203,295 | $40,849,089 | 2.14% |
| Versor Investments LP | 378,480 | $7,017,019 | 1.42% |
| Magnetar Financial LLC | 2,407,209 | $44,629,655 | 1.14% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,077,893 | $38,524,136 | 0.85% |
| Fort Baker Capital Management LP | 430,600 | $7,983,324 | 0.74% |
| EHP Funds Inc. | 84,210 | $1,561,253 | 0.73% |
| Terrapin Asset Management, LLC | 30,000 | $556,200 | 0.63% |
| AQR Arbitrage LLC | 734,970 | $13,626,344 | 0.61% |